ARECOR THERAPEUTICS PLC |
Market Closed -
London S.E.
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.50 GBX | 0.00% |
|
-20.95% | -20.41% |
| Jan. 10 | Arecor Therapeutics shares tumble as plans Tetris wind-down | AN |
| Jan. 10 | Arecor Therapeutics to Shutter Tetris Pharma Unit; Ends License Deal with Xeris | MT |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Revenues | 1.89M | 1.7M | 1.16M | 2.4M | 4.57M | |
Total Revenues | 1.89M | 1.7M | 1.16M | 2.4M | 4.57M | |
Gross Profit | 1.89M | 1.7M | 1.16M | 2.4M | 4.57M | |
Selling General & Admin Expenses, Total | 1.61M | 1.64M | 2.39M | 5.38M | 8.91M | |
R&D Expenses | 3.56M | 3.94M | 5.39M | 8.61M | 5.98M | |
Other Operating Expenses | -592K | -452K | -640K | -1.13M | -1.14M | |
Other Operating Expenses, Total | 4.58M | 5.13M | 7.14M | 12.86M | 13.75M | |
Operating Income | -2.69M | -3.43M | -5.98M | -10.46M | -9.18M | |
Interest Expense, Total | -13.07K | -82K | -22K | -26K | -15K | |
Interest And Investment Income | 9.41K | 2.98K | 1K | 109K | 284K | |
Net Interest Expenses | -3.66K | -79.02K | -21K | 83K | 269K | |
Other Non Operating Income (Expenses) | - | -5.29K | - | 5K | 5K | |
EBT, Excl. Unusual Items | -2.69M | -3.51M | -6M | -10.37M | -8.9M | |
Other Unusual Items | - | - | -947K | -171K | - | |
EBT, Incl. Unusual Items | -2.69M | -3.51M | -6.94M | -10.54M | -8.9M | |
Income Tax Expense | -502K | -760K | -776K | -1.28M | -347K | |
Earnings From Continuing Operations | -2.19M | -2.75M | -6.17M | -9.26M | -8.55M | |
Net Income to Company | -2.19M | -2.75M | -6.17M | -9.26M | -8.55M | |
Net Income - (IS) | -2.19M | -2.75M | -6.17M | -9.26M | -8.55M | |
Net Income to Common Incl Extra Items | -2.19M | -2.75M | -6.17M | -9.26M | -8.55M | |
Net Income to Common Excl. Extra Items | -2.19M | -2.75M | -6.17M | -9.26M | -8.55M | |
Per Share Items | ||||||
Net EPS - Basic | -0.14 | -0.17 | -0.27 | -0.32 | -0.28 | |
Basic EPS - Continuing Operations | -0.14 | -0.17 | -0.27 | -0.32 | -0.28 | |
Basic Weighted Average Shares Outstanding | 15.77M | 16.25M | 23.03M | 28.94M | 30.62M | |
Net EPS - Diluted | -0.14 | -0.17 | -0.27 | -0.32 | -0.28 | |
Diluted EPS - Continuing Operations | -0.14 | -0.17 | -0.27 | -0.32 | -0.28 | |
Diluted Weighted Average Shares Outstanding | 15.77M | 16.25M | 23.03M | 28.94M | 30.62M | |
Normalized Basic EPS | -0.11 | -0.14 | -0.16 | -0.22 | -0.18 | |
Normalized Diluted EPS | -0.11 | -0.14 | -0.16 | -0.22 | -0.18 | |
Supplemental Items | ||||||
EBITDA | -2.61M | -3.34M | -5.9M | -10.26M | -8.88M | |
EBITA | -2.68M | -3.42M | -5.97M | -10.37M | -9.08M | |
EBIT | -2.69M | -3.43M | -5.98M | -10.46M | -9.18M | |
EBITDAR | - | - | - | - | -8.44M | |
Effective Tax Rate - (Ratio) | 18.66 | 21.64 | 11.17 | 12.16 | 3.9 | |
Total Current Taxes | -502K | -760K | -776K | - | - | |
Normalized Net Income | -1.68M | -2.2M | -3.75M | -6.48M | -5.56M | |
Interest on Long-Term Debt | 7.62K | 17.98K | 22K | 18K | 15K | |
Supplemental Operating Expense Items | ||||||
General and Administrative Expenses | 1.61M | 1.64M | 2.39M | - | - | |
Research And Development Expense From Footnotes | 3.56M | 3.94M | 5.39M | 8.61M | 5.98M | |
Net Rental Expense, Total | - | - | - | - | 436K | |
Imputed Operating Lease Interest Expense | - | - | - | - | 167K | |
Imputed Operating Lease Depreciation | - | - | - | - | 269K | |
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | 156K | |
Stock-Based Comp., Other (Total) | 460K | 318K | 484K | 503K | 483K | |
Total Stock-Based Compensation | 460K | 318K | 484K | 503K | 639K |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Assets | ||||||
Cash And Equivalents | 3.07M | 2.9M | 18.32M | 4.76M | 5.09M | |
Short Term Investments | - | - | - | 8.04M | 1.66M | |
Total Cash And Short Term Investments | 3.07M | 2.9M | 18.32M | 12.81M | 6.75M | |
Accounts Receivable, Total | 497K | 78.3K | 712K | 2.22M | 2.27M | |
Other Receivables | 314K | 782K | 859K | 1.32M | 1.06M | |
Total Receivables | 811K | 860K | 1.57M | 3.54M | 3.32M | |
Inventory | - | - | - | 1.13M | 771K | |
Prepaid Expenses | 30.94K | 63.76K | 628K | - | 323K | |
Total Current Assets | 3.92M | 3.82M | 20.52M | 17.48M | 11.17M | |
Gross Property Plant And Equipment | 1.18M | 1.4M | 1.51M | 2.2M | 2.38M | |
Accumulated Depreciation | -888K | -1.03M | -1.18M | -1.36M | -1.55M | |
Net Property Plant And Equipment | 295K | 375K | 328K | 838K | 834K | |
Goodwill | - | - | - | 1.48M | 1.48M | |
Other Intangibles, Total | 46.53K | 38.2K | 30K | 1.92M | 1.81M | |
Other Long-Term Assets, Total | 48K | 48K | 48K | 48K | 77K | |
Total Assets | 4.31M | 4.28M | 20.92M | 21.76M | 15.38M | |
Liabilities | ||||||
Accounts Payable, Total | 366K | 464K | 518K | 1.71M | 2.25M | |
Accrued Expenses, Total | 271K | 691K | 1.17M | 1.27M | 2.13M | |
Current Portion of Leases | 97.73K | 105K | 126K | 202K | 118K | |
Current Income Taxes Payable | 46.61K | 51.11K | 85K | 120K | 100K | |
Unearned Revenue Current, Total | 241K | 80K | 349K | 206K | 232K | |
Other Current Liabilities | 15.75K | 16.31K | 23K | 217K | 321K | |
Total Current Liabilities | 1.04M | 1.41M | 2.27M | 3.73M | 5.15M | |
Long-Term Debt | - | 1.7M | - | - | - | |
Long-Term Leases | 60.39K | 192K | 105K | 86K | 220K | |
Deferred Tax Liability Non Current | - | - | - | 496K | 452K | |
Other Non Current Liabilities | - | 212K | - | - | 28K | |
Total Liabilities | 1.1M | 3.51M | 2.37M | 4.31M | 5.85M | |
Common Stock, Total | 26.73K | 27.16K | 278K | 306K | 306K | |
Additional Paid In Capital | 11.59M | 11.59M | 23.35M | 28.98M | 28.98M | |
Retained Earnings | -9.14M | -11.89M | -17.05M | -26.18M | -34.72M | |
Comprehensive Income and Other | 727K | 1.04M | 11.97M | 14.35M | 14.97M | |
Total Common Equity | 3.21M | 774K | 18.55M | 17.46M | 9.53M | |
Total Equity | 3.21M | 774K | 18.55M | 17.46M | 9.53M | |
Total Liabilities And Equity | 4.31M | 4.28M | 20.92M | 21.76M | 15.38M | |
Supplemental Items | ||||||
ECS Total Shares Outstanding on Filing Date | 15.77M | 27.68M | 27.84M | 30.62M | 30.63M | |
ECS Total Common Shares Outstanding | 15.77M | 16.29M | 27.84M | 30.62M | 30.63M | |
Book Value / Share | 0.2 | 0.05 | 0.67 | 0.57 | 0.31 | |
Tangible Book Value | 3.16M | 736K | 18.52M | 14.05M | 6.23M | |
Tangible Book Value Per Share | 0.2 | 0.05 | 0.67 | 0.46 | 0.2 | |
Total Debt | 158K | 2M | 231K | 288K | 338K | |
Net Debt | -2.92M | -903K | -18.08M | -12.52M | -6.41M | |
Debt Equivalent Oper. Leases | - | - | - | - | 3.49M | |
Account Code - Inventory Valuation | - | 3 | 3 | 3 | 3 | |
Inventories - Raw Materials, Total | - | - | - | 719K | 292K | |
Inventories - Finished Goods, Total | - | - | - | 412K | 479K | |
Machinery, Total | 673K | 706K | 762K | 1.17M | 1.18M | |
Full Time Employees | - | 29 | 37 | 51 | 50 | |
Part Time Employees | - | 1 | - | - | - |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Net Income | -2.19M | -2.75M | -6.17M | -9.26M | -8.55M | |
Depreciation & Amortization - CF | 143K | 160K | 163K | 248K | 390K | |
Amortization of Goodwill and Intangible Assets - (CF) | 8.33K | 8.33K | 8K | 91K | 97K | |
Depreciation & Amortization, Total | 152K | 169K | 171K | 339K | 487K | |
Amortization of Deferred Charges, Total - (CF) | - | - | - | 2K | 9K | |
Stock-Based Compensation (CF) | 460K | 318K | 484K | 503K | 638K | |
Other Operating Activities, Total | 801K | -338K | 483K | -705K | 688K | |
Change In Accounts Receivable | 446K | 384K | -1.26M | -48K | -1M | |
Change In Inventories | 11.39K | - | - | 587K | 360K | |
Change In Accounts Payable | -127K | 364K | 838K | -2.2M | 1.38M | |
Change in Other Net Operating Assets | - | - | - | - | 157K | |
Cash from Operations | -459K | -1.86M | -5.45M | -10.78M | -5.84M | |
Capital Expenditure | -32.3K | -52.29K | -69K | -299K | -151K | |
Sale of Property, Plant, and Equipment | - | - | - | - | 5K | |
Cash Acquisitions | - | - | - | 284K | - | |
Sale (Purchase) of Intangible assets | - | - | - | -46K | - | |
Investment in Marketable and Equity Securities, Total | - | - | - | -8.04M | 6.38M | |
Other Investing Activities, Total | 9.41K | 2.98K | 1K | 109K | 284K | |
Cash from Investing | -22.89K | -49.32K | -68K | -7.99M | 6.52M | |
Long-Term Debt Issued, Total | - | 1.91M | 2.5M | - | 38K | |
Total Debt Issued | - | 1.91M | 2.5M | - | 38K | |
Short Term Debt Repaid, Total | - | - | - | -295K | - | |
Long-Term Debt Repaid, Total | -69.89K | -49.22K | -112K | -165K | -203K | |
Total Debt Repaid | -120K | -49.22K | -112K | -460K | -203K | |
Issuance of Common Stock | 1.87K | 423 | 20M | 6M | - | |
Other Financing Activities, Total | -13.07K | -82.99K | -1.46M | -380K | -15K | |
Cash from Financing | -131K | 1.77M | 20.93M | 5.16M | -180K | |
Foreign Exchange Rate Adjustments | -27.06K | -42.94K | 5K | 62K | -171K | |
Net Change in Cash | -640K | -175K | 15.42M | -13.55M | 328K | |
Supplemental Items | ||||||
Cash Interest Paid | 13.07K | 17.98K | 22K | 28K | 15K | |
Cash Income Tax Paid (Refund) | -1.27M | -295K | -758K | -734K | -1.28M | |
Levered Free Cash Flow | -1.96M | -1.48M | -3.6M | -7.14M | -3M | |
Unlevered Free Cash Flow | -1.95M | -1.43M | -3.59M | -7.12M | -2.99M | |
Change In Net Working Capital | 459K | -282K | 437K | 1.09M | -1.76M | |
Net Debt Issued / Repaid | -120K | 1.86M | 2.39M | -460K | -165K |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | -47.47 | -49.89 | -29.64 | -30.63 | -30.88 | |
Return on Total Capital | -61.88 | -69.84 | -34.67 | -35.8 | -41.54 | |
Return On Equity % | -99.68 | -138.25 | -63.85 | -51.44 | -63.41 | |
Return on Common Equity | -99.68 | -138.25 | -63.85 | -51.44 | -63.41 | |
Margin Analysis | ||||||
Gross Profit Margin % | 100 | 100 | 100 | 100 | 100 | |
SG&A Margin | 84.94 | 96.7 | 206.3 | 223.93 | 194.9 | |
EBITDA Margin % | -138.07 | -196.75 | -509.59 | -426.97 | -194.18 | |
EBITA Margin % | -141.72 | -201.44 | -515.46 | -431.46 | -198.51 | |
EBIT Margin % | -142.16 | -201.93 | -516.15 | -435.25 | -200.63 | |
Income From Continuing Operations Margin % | -115.79 | -162.13 | -532.73 | -385.35 | -187.05 | |
Net Income Margin % | -115.79 | -162.13 | -532.73 | -385.35 | -187.05 | |
Net Avail. For Common Margin % | -115.79 | -162.13 | -532.73 | -385.35 | -187.05 | |
Normalized Net Income Margin | -88.97 | -129.31 | -323.73 | -269.74 | -121.65 | |
Levered Free Cash Flow Margin | -262.59 | -87.04 | -310.91 | -297.18 | -65.62 | |
Unlevered Free Cash Flow Margin | -260.59 | -84.02 | -309.73 | -296.5 | -65.41 | |
Asset Turnover | ||||||
Asset Turnover | 0.2 | 0.4 | 0.09 | 0.11 | 0.25 | |
Fixed Assets Turnover | 1.89 | 5.06 | 3.29 | 4.12 | 5.47 | |
Receivables Turnover (Average Receivables) | 1.42 | 5.9 | 2.93 | 1.64 | 3.12 | |
Short Term Liquidity | ||||||
Current Ratio | 3.78 | 2.71 | 9.05 | 4.69 | 2.17 | |
Quick Ratio | 3.75 | 2.67 | 8.77 | 4.38 | 1.96 | |
Operating Cash Flow to Current Liabilities | -0.44 | -1.32 | -2.4 | -2.89 | -1.13 | |
Days Sales Outstanding (Average Receivables) | 257.17 | 62.05 | 124.5 | 222.3 | 117.01 | |
Long Term Solvency | ||||||
Total Debt/Equity | 4.93 | 257.87 | 1.25 | 1.65 | 3.55 | |
Total Debt / Total Capital | 4.7 | 72.06 | 1.23 | 1.62 | 3.43 | |
LT Debt/Equity | 1.88 | 244.27 | 0.57 | 0.49 | 2.31 | |
Long-Term Debt / Total Capital | 1.79 | 68.26 | 0.56 | 0.48 | 2.23 | |
Total Liabilities / Total Assets | 25.49 | 81.94 | 11.34 | 19.8 | 38.04 | |
EBIT / Interest Expense | -205.66 | -41.81 | -271.68 | -402.27 | -611.67 | |
EBITDA / Interest Expense | -194.07 | -39.75 | -263.91 | -389.23 | -579.2 | |
(EBITDA - Capex) / Interest Expense | -196.54 | -40.39 | -267.05 | -400.73 | -589.27 | |
Total Debt / EBITDA | -0.06 | -0.61 | -0.04 | -0.03 | -0.04 | |
Net Debt / EBITDA | 1.15 | 0.28 | 3.11 | 1.24 | 0.74 | |
Total Debt / (EBITDA - Capex) | -0.06 | -0.6 | -0.04 | -0.03 | -0.04 | |
Net Debt / (EBITDA - Capex) | 1.13 | 0.27 | 3.08 | 1.2 | 0.73 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | -44.62 | -10.23 | -31.8 | 107.51 | 90.3 | |
Gross Profit, 1 Yr. Growth % | -44.62 | -10.23 | -31.8 | 107.51 | 90.3 | |
EBITDA, 1 Yr. Growth % | 111.65 | 27.93 | 76.68 | 73.87 | -12.44 | |
EBITA, 1 Yr. Growth % | 104.89 | 27.61 | 74.53 | 73.7 | -11.43 | |
EBIT, 1 Yr. Growth % | 104.26 | 27.52 | 74.36 | 74.99 | -11.28 | |
Earnings From Cont. Operations, 1 Yr. Growth % | 117.58 | 25.71 | 124.16 | 50.11 | -7.62 | |
Net Income, 1 Yr. Growth % | 117.58 | 25.71 | 124.16 | 50.11 | -7.62 | |
Normalized Net Income, 1 Yr. Growth % | 101.26 | 30.48 | 70.79 | 72.91 | -13.19 | |
Diluted EPS Before Extra, 1 Yr. Growth % | 57.58 | 22 | 58.12 | 19.49 | -12.71 | |
Accounts Receivable, 1 Yr. Growth % | 62.11 | -84.25 | 812.82 | 211.1 | 241.57 | |
Inventory, 1 Yr. Growth % | - | - | - | - | -31.83 | |
Net Property, Plant and Equip., 1 Yr. Growth % | -19.49 | 27.18 | -12.77 | 155.49 | -0.48 | |
Total Assets, 1 Yr. Growth % | 163.75 | -0.51 | 388.35 | 4.03 | -29.35 | |
Tangible Book Value, 1 Yr. Growth % | 582.02 | -76.73 | 2.42K | -24.12 | -55.66 | |
Common Equity, 1 Yr. Growth % | 528.92 | -75.88 | 2.3K | -5.9 | -45.42 | |
Cash From Operations, 1 Yr. Growth % | 408.51 | 304.67 | 193.48 | 97.8 | -45.82 | |
Capital Expenditures, 1 Yr. Growth % | 466.13 | 61.91 | 32.69 | 333.33 | -49.5 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | 143.59 | 98.34 | -57.52 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | 151.37 | 98.65 | -57.58 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | - | -21.75 | 18.96 | 98.72 | |
Gross Profit, 2 Yr. CAGR % | - | - | -21.75 | 18.96 | 98.72 | |
EBITDA, 2 Yr. CAGR % | - | - | 50.34 | 75.27 | 22.67 | |
EBITA, 2 Yr. CAGR % | - | - | 49.24 | 74.11 | 23.32 | |
EBIT, 2 Yr. CAGR % | - | - | 49.11 | 74.67 | 23.9 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | 67.85 | 83.43 | 17.75 | |
Net Income, 2 Yr. CAGR % | - | - | 67.85 | 83.43 | 17.75 | |
Normalized Net Income, 2 Yr. CAGR % | - | - | 49.27 | 71.84 | 21.82 | |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | 38.88 | 37.45 | 2.13 | |
Accounts Receivable, 2 Yr. CAGR % | - | - | 19.66 | 432.89 | 78.48 | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | 5.42 | 49.29 | 59.46 | |
Total Assets, 2 Yr. CAGR % | - | - | 120.43 | 125.4 | -14.27 | |
Tangible Book Value, 2 Yr. CAGR % | - | - | 142.03 | 336.96 | -41.99 | |
Common Equity, 2 Yr. CAGR % | - | - | 140.46 | 374.89 | -28.33 | |
Cash From Operations, 2 Yr. CAGR % | - | - | 244.66 | 140.94 | 3.52 | |
Capital Expenditures, 2 Yr. CAGR % | - | - | 46.16 | 139.79 | 47.93 | |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 119.81 | -8.71 | |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 123.46 | -8.67 | |
Compound Annual Growth Rate Over Three Years | ||||||
Total Revenues, 3 Yr. CAGR % | - | - | - | 8.31 | 39.13 | |
Gross Profit, 3 Yr. CAGR % | - | - | - | 8.31 | 39.13 | |
EBITDA, 3 Yr. CAGR % | - | - | - | 57.8 | 38.53 | |
EBITA, 3 Yr. CAGR % | - | - | - | 56.99 | 38.46 | |
EBIT, 3 Yr. CAGR % | - | - | - | 57.28 | 38.84 | |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | - | 61.72 | 45.94 | |
Net Income, 3 Yr. CAGR % | - | - | - | 61.72 | 45.94 | |
Normalized Net Income, 3 Yr. CAGR % | - | - | - | 56.77 | 36.34 | |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | 32.09 | 18.15 | |
Accounts Receivable, 3 Yr. CAGR % | - | - | - | 64.54 | 207.5 | |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | 41.61 | 30.41 | |
Total Assets, 3 Yr. CAGR % | - | - | - | 71.62 | 53.11 | |
Tangible Book Value, 3 Yr. CAGR % | - | - | - | 64.42 | 103.81 | |
Common Equity, 3 Yr. CAGR % | - | - | - | 75.89 | 130.89 | |
Cash From Operations, 3 Yr. CAGR % | - | - | - | 186.42 | 46.52 | |
Capital Expenditures, 3 Yr. CAGR % | - | - | - | 109.97 | 42.67 | |
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | 26.62 | |
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | 27.99 |